Biosafety assessment of delivery systems for clinical nucleic acid therapeutics
Nucleic acid therapeutics, which involve transferring exogenous genes inside target cells, are a promising clinical treatment option that can regulate gene expression at the transcriptional or post-transcriptional level. Ideally, this kind of treatment modality will not lead to an unwanted immune re...
Main Authors: | Zhimin Li, Li Zhang, Kai Jiang, Yijing Zhang, Yonglin Liu, Guang Hu, Jie Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-04-01
|
Series: | Biosafety and Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590053622000258 |
Similar Items
-
Delivery of nucleic acids using nanomaterials
by: Yuyang Qin, et al.
Published: (2023-12-01) -
The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery
by: Ruvanthi N. Kularatne, et al.
Published: (2022-07-01) -
Delivery and Biosafety of Oncolytic Virotherapy
by: Lizhi Li, et al.
Published: (2020-04-01) -
Delivery of nucleic acid therapeutics for cancer immunotherapy
by: Shurong Zhou, et al.
Published: (2020-06-01) -
New Applications of Lipid and Polymer-Based Nanoparticles for Nucleic Acids Delivery
by: Adelina-Gabriela Niculescu, et al.
Published: (2021-12-01)